Publications
Nightingale Health’s technology is routinely used in world-class epidemiological and genetic studies. There are over 600 publications that have utilized our technology.
Highlighted publications
←
→
Metabolomic profiles predict individual multidisease outcomes
Buergel et al., Nat Med., 2022
Atlas of plasma NMR biomarkers for health and disease in 118,461 individuals from the UK Biobank
Julkunen et al., Nat Commun., 2023
Genome-wide characterization of circulating metabolic biomarkers
Karjalainen et al., Nature, 2024
All
Ageing & dementia
Cancer
Cardiovascular disease
Diabetes
Exposome & nutrition
Genetics
Inflammation & immunity
Kidney disease
Liver disease
Lung disease
Maternal & child health
Medicines & trials
Methods
Mortality & multi-morbidity
Obesity & bodyweight
Psychiatric disorders
Risk prediction
H. Xu et. al, Clinical Nutrition, 2023
T. Geng et. al, American Journal of Kidney Diseases, 2023
Genetics, Diabetes, Cardiovascular disease
Using genetics to examine the overall and sex-specific associations of branch-chain amino acids and the valine metabolite, 3-hydroxyisobutyrate, with ischemic heart disease and diabetes: A two-sample Mendelian randomization study
J. Zhao et. al, Atherosclerosis, 2023
Cardiovascular disease
Discovery and validation of circulating stroke metabolites by NMR-based analyses using patients from the MISS and UK Biobank
M. Rout et. al, Neurochemistry International, 2023
Diabetes
Associations of Clinical Risk Factors and Novel Biomarkers With Age at Onset of Type 2 Diabetes
J. Chen et. al, The Journal of Clinical Endocrinology & Metabolism, 2023
Exposome & nutrition, Psychiatric disorders
Long-term ambient ozone, omega-3 fatty acid, genetic susceptibility, and risk of mental disorders among middle-aged and older adults in UK biobank
J. Jin et. al, Environmental Research, 2023
Ageing & dementia, Exposome & nutrition
Plasma Omega-3 Fatty Acids and Risk for Incident Dementia in the UK Biobank Study: A Closer Look
A. Sala-Vila et. al, Nutrients, 2023
Risk prediction, Ageing & dementia, Mortality & multi-morbidity
Metabolic biomarkers using nuclear magnetic resonance metabolomics assay for the prediction of aging-related disease risk and mortality: a prospective, longitudinal, observational, cohort study based on the UK Biobank
J. Lian et. al, GeroScience, 2023
Mortality & multi-morbidity, Cardiovascular disease
The relationship of fatty acids to ischaemic heart disease and lifespan in men and women using Mendelian randomization
C. Schooling et. al, International Journal of Epidemiology, 2023
Cardiovascular disease
Associations of circulating fatty acids with incident coronary heart disease: a prospective study of 89,242 individuals in UK Biobank
D. Jin et. al, BMC Cardiovascular Disorders, 2023
Cardiovascular disease, Exposome & nutrition
The Association of Metabolomic Profiles of a Healthy Lifestyle with Heart Failure Risk in a Prospective Study
Y. Ma et. al, Nutrients, 2023
Psychiatric disorders
A Machine Learning Analysis of Big Metabolomics Data for Classifying Depression: Model Development and Validation
S. Ma et. al, Biological Psychiatry, 2023
L. Amente et. al, Human Genetics, 2023
Risk prediction, Genetics
Metabolomic profiles, polygenic risk scores and risk of rheumatoid arthritis: a population-based cohort study in the UK Biobank
X. Fang et. al, RMD Open, 2023
Cardiovascular disease, Genetics
Causal role of lipid metabolome on the risk of ischemic stroke, its etiological subtypes, and long-term outcome: A Mendelian randomization study
J. Martín-Campos et. al, Atherosclerosis, 2023